The future of analytical technology and molecular diagnostics
Our approach to life sciences consulting is truly collaborative. We love to assemble multidisciplinary teams of talented engineers and scientists from our global locations to stretch the boundaries of what’s considered possible. Talk to us about bringing your breakthrough technology, biology or analytics to the world.
Life sciences case studies
UK Government ventilator challenge
Creating Veloci-Vent, a sophisticated emergency ventilator, in six weeks
- Product realisation
CATALOG DNA data encoding machine
Enabling the world's first DNA-based platform for massive data storage
- Bioinnovation
Ellume COVID-19 Home Test
A major milestone, enabled by our breakthrough sensing technology.
- Bioinnovation
- Digital health
PureSentry contamination detection
A scalable, fully automated system for cell and gene therapy monitoring
- Bioinnovation
Life sciences product development facilities
Life science labs
Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.
Microfluidics lab
Our microfluidics lab is equipped to rapidly prototype Polydimethylsiloxane (PDMS) microfluidic devices in a clean environment. We optically inspect functioning test cartridges with state-of-the-art microscopy, and measure particle size distributions with a Spraytec laser diffraction system.
Optics labs
Our suite optics labs enable us to build complex and high-precision optical layouts, typically for testing prototype designs and novel techniques prior to deployment. Featuring six high-spec optical benches with configurable interlocked controlled areas for high-power (class 4) laser work and specialist facilities for interferometry, spectroscopy, low-noise fluorescence imaging and photon counting. This space can be split into separate laser-controlled areas, allowing multiple experiments to run simultaneously, giving our optical engineers the capability to develop creative solutions without instrumentation restrictions.
Digital Greenhouse
The Digital Greenhouse is our purpose-built AI research facility, specifically designed to discover, develop and test machine learning approaches in a fast, secure environment. The facility features an NVIDIA DGX-1 Deep Learning Supercomputer, a bank of machine learning computers, petabyte local storage and many teraflops of dedicated compute power.
Why work with our life sciences team?
Thousands of successful projects, deep in-house multidisciplinary expertise and a rich, 60-year heritage marks CC out from other life sciences consulting companies. Collaborate with us, and you’ll enjoy full control to switch resources on and off – or pivot your project to embrace complementary skillsets. Why not get in touch for an initial, no obligation chat? If there’s a good fit, we’ll define a suitable work programme for the most complex of challenges. If not, we’ll let you know as soon as possible and suggest a more appropriate way forward.
We deal with unique challenges, so our quoting process is a flexible. We’re always keen to listen to your feedback so we can tailor the scope till it’s just right. To kick off a conversation, please email lifesciences@cambridgeconsultants.com with a brief overview of your life sciences challenge or area of interest. We’ll match your request to the right expertise this end and get back to you within 48 hours.
News & Insights
From assay through design to insight – bringing biology and engineering together
Biology, chemistry, engineering and AI are obviously very different disciplines. But our determination to make them work closely together has enabled some truly remarkable progress. Symon Cotton, Head of Life Sciences, says that harnessing these fields and embracing the different ways scientists and engineers work has improved the development of breakthrough medical products…
- Digital health
- Human factors
Why digital biomarkers are vital for a patient-empowering connected health future
The pandemic has accelerated our path towards an inevitable conclusion – a digitally connected healthcare future that empowers both patients and carers alike. The opportunities are out there, so what’s the next step for pharma companies and device developers with ambitions in the space?
- Digital health
In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits
The current state of in vitro diagnostics is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits...
- Digital health
- Human factors
Time to get emotional – my top six insights into successful medical device design
Six insights into successful medical device design. Designing a medical device is a challenging creative task. Not only must it be safe, reliable, easy to use and have market appeal, the device must be accepted into people’s lives and lifestyles...
- Human factors
- Industrial design
- User Experience (UX)
Meet the life sciences team
Symon Cotton
Associate Director
Andrew Goulter
Associate Director
Yan Lin Lye
Head of Medtech APAC
Karen Weisinger
Head of cell biology,
US Global Med Tech
Joe Corrigan
Head of Intelligent Healthcare
Mark West
Associate Chief Engineer
Upcoming and previous events
Molecular Med TRI-CON Virtual Conference and Expo
Molecular Medicine Tri-Conference has served as the leading international meeting place for the precision medicine community. The three-day conference and exhibition consists of a program of virtual presentations from international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics, vaccines and biotherapeutics, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence.
- Bioinnovation
- Fluids & thermodynamics
- Physical sciences
- Sensing
Synbiobeta 2022
At Synbiobeta 2022 see how synthetic biology is disrupting consumer products, food, agriculture, medicine, chemicals, materials, and more. The Synbiobeta Global Synthetic Biology Conference 2022 unites the leading biological engineers, investors, innovators, and entrepreneurs who make up this fast-growing industry.
Cambridge Consultants James Hallinan, head of business development for bioinnovation will be hosting a panel discussing making advanced therapies affordable to all.
- Bioinnovation
Medtech Connect Osaka 2022 | The challenges to realising next generation therapeutics
The race to bring the promise of advanced therapies to Japanese patients
- Bioinnovation
AGBT | Precision Health 2022
Bringing together leading genomic researchers, healthcare professionals, and healthcare industry stakeholders to usher in a new era of precision medicine.
- Digital health
- Human factors